Reconnecting

The current page stays visible while onset.to reconnects in the background.

onset.to

← All weeks

Highlights Sep 28 - Oct 4, 2026

new every Sunday

This week brought an early clinical signal for ayahuasca-assisted grief therapy, a rare kratom safety case, and renewed debate over federal drug policy and oversight.

  1. 01 Exploratory clinical trial finds ayahuasca combined with meaning reconstruction therapy may ease severe bereavement

    An 84-person exploratory trial found sustained grief and well-being gains with ayahuasca-assisted meaning reconstruction therapy.

    psypost.org · Sep 27, 2026 Ayahuasca Clinical
  2. 02 Kratom-Tee löst bei gesundem 22-Jährigen erstmals in Österreich einen akuten Herzstillstand aus

    A healthy 22-year-old suffered two cardiac arrests after kratom tea, raising concern about severe, potentially overlooked toxicity.

    tirol.orf.at · Sep 28, 2026 Other Safety
  3. 03 MAPS opposes the DEA's attempt to place five lesser-known tryptamines into Schedule I under the Controlled Substances Act

    MAPS is challenging the DEA's renewed bid to place five lesser-known tryptamines in Schedule I, citing research and criminalization costs.

    maps.org · Sep 29, 2026 Other Policy
  4. 04 Is HHS too cosy with the psychedelic industry, and is the public being misled about psychedelic risks?

    This critique examines alleged HHS-industry ties and asks whether official messaging understates prolonged psychological risks.

    ecstaticintegration.org · Oct 2, 2026 LSD Policy